Bálint E E, Vousden K H
NCI at Frederick, National Institutes of Health, Building 560, Room 22-96, 1050 Boyles Street, Frederick, MD 21702-1201, USA.
Br J Cancer. 2001 Dec 14;85(12):1813-23. doi: 10.1054/bjoc.2001.2128.
The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy.
p53肿瘤抑制蛋白通过介导细胞应激后的细胞周期阻滞、凋亡或修复来抑制恶性进展。p53功能的主要调节因子之一是MDM2蛋白,多种细胞应激形式通过抑制MDM2介导的p53降解来激活p53。p53突变或允许p53激活的信号通路的破坏似乎是所有癌症的一个普遍特征。在此,我们综述了我们对调节p53的信号通路以及由p53诱导的信号通路的最新认识进展,以及它们对癌症治疗的意义。